Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

Barry Trachtenberg, Darcy L. Velazquez, Adam R. Williams, Ian McNiece, Joel Fishman, Kim Nguyen, Didier Rouy, Peter Altman, Richard Schwarz, Adam Mendizabal, Behzad Oskouei, John Byrnes, Victor Soto, Melissa Tracy, Juan Pablo Zambrano, Alan W. Heldman, Joshua M. Hare

Research output: Contribution to journal › Article › peer-review

131 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy'. Together they form a unique fingerprint.

Fingerprint

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience